Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy R Peck

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Iscience|September 4, 2023
Machine learning reveals genetic modifiers of the immune microenvironment of cancerBridget Riley-Gillis, Shirng-Wern Tsaih, Emily King, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2018
Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cellsVictoria J Gennaro, Timothy J Stanek, Amy R Peck, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 18, 2016
Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platformsAmy R Peck, Melanie A Girondo, Chengbao Liu, et al.
Cell Reports|May 11, 2024
The Janus kinase 1 is critical for pancreatic cancer initiation and progressionHridaya Shrestha, Patrick D Rädler, Rayane Dennaoui, et al.
Cancers|January 21, 2022
Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast CancerBrenton A Maisel, Misung Yi, Amy R Peck, et al.
Breast Cancer Research : BCR|September 6, 2013
Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironmentNing Yang, Chengbao Liu, Amy R Peck, et al.
Cancer Cell|February 16, 2017
Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor MicroenvironmentKanstantsin V Katlinski, Jun Gui, Yuliya V Katlinskaya, et al.
Molecular Cancer Research : MCR|November 15, 2022
Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer CellsNoreen McBrearty, Christina Cho, Jinyun Chen, et al.
The Journal of Clinical Investigation|May 17, 2021
Regulation of intercellular biomolecule transfer-driven tumor angiogenesis and responses to anticancer therapiesZhen Lu, Angelica Ortiz, Ioannis I Verginadis, et al.
Breast Cancer Research and Treatment|June 6, 2019
Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcomeCody Plasterer, Shirng-Wern Tsaih, Amy R Peck, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Iscience|September 4, 2023
Machine learning reveals genetic modifiers of the immune microenvironment of cancerBridget Riley-Gillis, Shirng-Wern Tsaih, Emily King, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2018
Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cellsVictoria J Gennaro, Timothy J Stanek, Amy R Peck, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 18, 2016
Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platformsAmy R Peck, Melanie A Girondo, Chengbao Liu, et al.
Cell Reports|May 11, 2024
The Janus kinase 1 is critical for pancreatic cancer initiation and progressionHridaya Shrestha, Patrick D Rädler, Rayane Dennaoui, et al.
Cancers|January 21, 2022
Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast CancerBrenton A Maisel, Misung Yi, Amy R Peck, et al.
Breast Cancer Research : BCR|September 6, 2013
Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironmentNing Yang, Chengbao Liu, Amy R Peck, et al.
Cancer Cell|February 16, 2017
Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor MicroenvironmentKanstantsin V Katlinski, Jun Gui, Yuliya V Katlinskaya, et al.
Molecular Cancer Research : MCR|November 15, 2022
Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer CellsNoreen McBrearty, Christina Cho, Jinyun Chen, et al.
The Journal of Clinical Investigation|May 17, 2021
Regulation of intercellular biomolecule transfer-driven tumor angiogenesis and responses to anticancer therapiesZhen Lu, Angelica Ortiz, Ioannis I Verginadis, et al.
Breast Cancer Research and Treatment|June 6, 2019
Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcomeCody Plasterer, Shirng-Wern Tsaih, Amy R Peck, et al.
Pageof 3